Results 121 to 130 of about 2,024,119 (265)
Yuji Watanabe,1,2 Nozomi Oikawa,1,2 Maya Hariu,1,2 Masafumi Seki11Division of Infectious Diseases and Infection Control; 2Laboratory for Clinical Microbiology, Tohoku Medical and Pharmaceutical University Hospital, Sendai City, Miyagi, JapanBackground ...
Watanabe Y, Oikawa N, Hariu M, Seki M
doaj
Methicillin-resistant Staphylococcus aureus (MRSA) represents a considerable challenge to global health owing to its resistance to antibiotics. In our prior research, we identified four ent-kaurane diterpenoids (compounds 1–4) isolated from Siegesbeckia ...
Yuan Yang +5 more
doaj +1 more source
Nonthermal plasma approaches for combating implant‐associated infections: A compendious review
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe +8 more
wiley +1 more source
Progress in bone tissue engineering biomaterials: Development, challenges, and prospects
Scheme 1 Application of biomaterials in immunomodulation during bone tissue engineering. Abstract Bone defect repair remains a major clinical challenge in orthopedics. Over 2 million cases caused by trauma, tumors, and other factors occur annually, with large‐scale defects posing a particular bottleneck due to limited self‐healing capacity.
Yuanbin Zhang +7 more
wiley +1 more source
Large‐Scale Applications of Plasma Technologies: Progresses and Challenges
ABSTRACT Plasma technologies convert electrical power into energetic electrons, ions, reactive species, radiation and heat, thereby breaking through the bottleneck of purely thermal or chemical routes and bringing impressive changes to our world. This roadmap reviews the progress and challenges of plasma technologies from a large‐scale and application ...
Pankaj Attri +51 more
wiley +1 more source
<p>Goldstein ND, Jenness SM, Tuttle D, Power M, Paul DA. Evaluating a neonatal intensive care unit MRSA surveillance programme using agent-based network modelling.
Neal D. Goldstein
core +1 more source
ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim +7 more
wiley +1 more source
Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat that requires novel antimicrobials to combat this WHO-designated priority pathogen.
Arti Rathore +8 more
doaj +1 more source
ABSTRACT Among bacteria that are associated with the development and/or exacerbation of allergic/atopic diseases, several have been described to produce IgE‐binding components. However, only one bacterial protein, Bac s 1, is currently listed in the official database of the World Health Organization/International Union of Immunological Societies (WHO ...
Uta Jappe +24 more
wiley +1 more source
MRSA is one of common multi-drug resistant bacteria and it can cause infections everywhere in or body. In my thesis, basic knowledges about Staphylococcus aureus and MRSA are reviewed first.
Matsuo, Miki
core

